Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Future Directions for Precision Medicine in Advanced NSCLC
EP. 1: Advances in Frontline Therapy for EGFR+ NSCLC
October 23rd 2018
EP. 2: Resistance Mechanisms and Sequencing for EGFR+ NSCLC
October 23rd 2018
EP. 3: Promising EGFR Inhibitors in Development for NSCLC
October 23rd 2018
EP. 4: Frontline Chemo and TKI Combination in EGFR+ NSCLC
October 23rd 2018
EP. 5: Adjuvant TKI for Early Stage EGFR+ NSCLC
October 23rd 2018
EP. 6: Updates in the Treatment of ALK+ and ROS1+ NSCLC
October 23rd 2018
EP. 7: Practice-Changing Frontline Treatment of ALK+ NSCLC
October 23rd 2018
EP. 8: Second Generation ALK Inhibitors in NSCLC
October 23rd 2018
EP. 9: Additional Targets in NSCLC: BRAF V600E and BRAF Variants
October 23rd 2018
EP. 10: NTRK Gene Fusions: Rare Yet Actionable
October 23rd 2018
EP. 11: Targeting HER2 Mutations in NSCLC: What Do We Know?
October 23rd 2018
EP. 12: Response Rates in Treatment of MET-Amplified NSCLC
October 23rd 2018
EP. 13: Advances in RET Inhibition in NSCLC
October 23rd 2018
EP. 14: Mutation Testing for All Patients With NSCLC
October 23rd 2018
x